Terms: = Testicular cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
8 results:
1. National burden of cancer in Italy, 1990-2017: a systematic analysis for the global burden of disease study 2017.
Bosetti C; Traini E; Alam T; Allen CA; Carreras G; Compton K; Fitzmaurice C; Force LM; Gallus S; Gorini G; Harvey JD; Kocarnik JM; La Vecchia C; Lugo A; Naghavi M; Pennini A; Piccinelli C; Ronfani L; Xu R; Monasta L
Sci Rep; 2020 Dec; 10(1):22099. PubMed ID: 33328623
[TBL] [Abstract] [Full Text] [Related]
2. Trends and Patterns of Disparities in cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
3. testicular self-examination and testicular cancer: a cost-utility analysis.
Aberger M; Wilson B; Holzbeierlein JM; Griebling TL; Nangia AK
Cancer Med; 2014 Dec; 3(6):1629-34. PubMed ID: 25103095
[TBL] [Abstract] [Full Text] [Related]
4. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract] [Full Text] [Related]
5. Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion.
Kuhn JM; Lefebvre H; Duparc C; Pellerin A; Luton JP; Strauch G
J Clin Endocrinol Metab; 2002 May; 87(5):2367-75. PubMed ID: 11994389
[TBL] [Abstract] [Full Text] [Related]
6. Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients.
Gutierrez-Delgado F; Titov DA; Tjulandin SA; Garin AM
Neoplasma; 1999; 46(3):190-5. PubMed ID: 10613596
[TBL] [Abstract] [Full Text] [Related]
7. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
Bokemeyer C; Fels LM; Dunn T; Voigt W; Gaedeke J; Schmoll HJ; Stolte H; Lentzen H
Br J Cancer; 1996 Dec; 74(12):2036-41. PubMed ID: 8980410
[TBL] [Abstract] [Full Text] [Related]
8. [Radiotherapy of testicular infiltration in childhood leukemia].
Zhang S
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):219-21. PubMed ID: 2612336
[TBL] [Abstract] [Full Text] [Related]
